Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis.
Vergou
Theognosia
T
Moustou
Aikaterini E
AE
Maniateas
Apostolos
A
Stratigos
Alexander J
AJ
Katsambas
Andreas
A
Antoniou
Christina
C
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005451:Fluorescein Angiography; D006801:Humans; D006949:Hyperlipidemias; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D009887:Ophthalmoscopy; D011565:Psoriasis / Q000188:drug therapy; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000175:diagnosis; D012907:Smoking; D041623:Tomography, Optical Coherence
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab